APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fexofenadine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Fexofenadine Industry Research Report 2026

Report ID 173991510522 December 2025139 pages

Choose your research edition.

Industry ResearchFexofenadine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Fexofenadine Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Fexofenadine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fexofenadine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Fexofenadine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Fexofenadine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Fexofenadine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Fexofenadine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Fexofenadine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Fexofenadine include Zhejiang Excel Pharmaceutical, VPL Chemicals, Viruj Pharma, Va Sudha Pharma Chem Limited, Titan Pharma, Synkromax, Sumitomo Chemical, Smaart Pharmaceutticals and Sibram, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Fexofenadine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Fexofenadine Market by Company

Zhejiang Excel Pharmaceutical

VPL Chemicals

Viruj Pharma

Va Sudha Pharma Chem Limited

Titan Pharma

Synkromax

Sumitomo Chemical

Smaart Pharmaceutticals

Sibram

Panchsheel

JRC

Gen Pharma

Farmhispania

CEPiA-Sanofi

Cemex Pharma

CAMEO HEALTH CARE

Archerchem

AFCL

Admiron Life Sciences Private Limited

Fexofenadine Segment by Type

Purity:98%

Purity:Above 98%

Fexofenadine Segment by Application

Hay Fever Treatment

Urticaria Treatment

Fexofenadine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fexofenadine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fexofenadine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fexofenadine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Fexofenadine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Fexofenadine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Fexofenadine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Fexofenadine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Fexofenadine Sales (k units) of Manufacturers (2021-2026) Table 7. Global Fexofenadine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Fexofenadine Revenue of Manufacturers (2021-2026) Table 9. Global Fexofenadine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Fexofenadine Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Fexofenadine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Fexofenadine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Fexofenadine, Product Type & Application Table 14. Global Fexofenadine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Fexofenadine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Excel Pharmaceutical Company Information Table 19. Zhejiang Excel Pharmaceutical Business Overview Table 20. Zhejiang Excel Pharmaceutical Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zhejiang Excel Pharmaceutical Fexofenadine Product Portfolio Table 22. Zhejiang Excel Pharmaceutical Recent Developments Table 23. VPL Chemicals Company Information Table 24. VPL Chemicals Business Overview Table 25. VPL Chemicals Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. VPL Chemicals Fexofenadine Product Portfolio Table 27. VPL Chemicals Recent Developments Table 28. Viruj Pharma Company Information Table 29. Viruj Pharma Business Overview Table 30. Viruj Pharma Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Viruj Pharma Fexofenadine Product Portfolio Table 32. Viruj Pharma Recent Developments Table 33. Va Sudha Pharma Chem Limited Company Information Table 34. Va Sudha Pharma Chem Limited Business Overview Table 35. Va Sudha Pharma Chem Limited Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Va Sudha Pharma Chem Limited Fexofenadine Product Portfolio Table 37. Va Sudha Pharma Chem Limited Recent Developments Table 38. Titan Pharma Company Information Table 39. Titan Pharma Business Overview Table 40. Titan Pharma Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Titan Pharma Fexofenadine Product Portfolio Table 42. Titan Pharma Recent Developments Table 43. Synkromax Company Information Table 44. Synkromax Business Overview Table 45. Synkromax Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Synkromax Fexofenadine Product Portfolio Table 47. Synkromax Recent Developments Table 48. Sumitomo Chemical Company Information Table 49. Sumitomo Chemical Business Overview Table 50. Sumitomo Chemical Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Sumitomo Chemical Fexofenadine Product Portfolio Table 52. Sumitomo Chemical Recent Developments Table 53. Smaart Pharmaceutticals Company Information Table 54. Smaart Pharmaceutticals Business Overview Table 55. Smaart Pharmaceutticals Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Smaart Pharmaceutticals Fexofenadine Product Portfolio Table 57. Smaart Pharmaceutticals Recent Developments Table 58. Sibram Company Information Table 59. Sibram Business Overview Table 60. Sibram Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Sibram Fexofenadine Product Portfolio Table 62. Sibram Recent Developments Table 63. Panchsheel Company Information Table 64. Panchsheel Business Overview Table 65. Panchsheel Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Panchsheel Fexofenadine Product Portfolio Table 67. Panchsheel Recent Developments Table 68. JRC Company Information Table 69. JRC Business Overview Table 70. JRC Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. JRC Fexofenadine Product Portfolio Table 72. JRC Recent Developments Table 73. Gen Pharma Company Information Table 74. Gen Pharma Business Overview Table 75. Gen Pharma Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Gen Pharma Fexofenadine Product Portfolio Table 77. Gen Pharma Recent Developments Table 78. Farmhispania Company Information Table 79. Farmhispania Business Overview Table 80. Farmhispania Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Farmhispania Fexofenadine Product Portfolio Table 82. Farmhispania Recent Developments Table 83. CEPiA-Sanofi Company Information Table 84. CEPiA-Sanofi Business Overview Table 85. CEPiA-Sanofi Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. CEPiA-Sanofi Fexofenadine Product Portfolio Table 87. CEPiA-Sanofi Recent Developments Table 88. Cemex Pharma Company Information Table 89. Cemex Pharma Business Overview Table 90. Cemex Pharma Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Cemex Pharma Fexofenadine Product Portfolio Table 92. Cemex Pharma Recent Developments Table 93. CAMEO HEALTH CARE Company Information Table 94. CAMEO HEALTH CARE Business Overview Table 95. CAMEO HEALTH CARE Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. CAMEO HEALTH CARE Fexofenadine Product Portfolio Table 97. CAMEO HEALTH CARE Recent Developments Table 98. Archerchem Company Information Table 99. Archerchem Business Overview Table 100. Archerchem Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Archerchem Fexofenadine Product Portfolio Table 102. Archerchem Recent Developments Table 103. AFCL Company Information Table 104. AFCL Business Overview Table 105. AFCL Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. AFCL Fexofenadine Product Portfolio Table 107. AFCL Recent Developments Table 108. Admiron Life Sciences Private Limited Company Information Table 109. Admiron Life Sciences Private Limited Business Overview Table 110. Admiron Life Sciences Private Limited Fexofenadine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Admiron Life Sciences Private Limited Fexofenadine Product Portfolio Table 112. Admiron Life Sciences Private Limited Recent Developments Table 113. Global Fexofenadine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Fexofenadine Sales by Region (2021-2026) & (k units) Table 115. Global Fexofenadine Sales Market Share by Region (2021-2026) Table 116. Global Fexofenadine Sales by Region (2027-2032) & (k units) Table 117. Global Fexofenadine Sales Market Share by Region (2027-2032) Table 118. Global Fexofenadine Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Fexofenadine Revenue Market Share by Region (2021-2026) Table 120. Global Fexofenadine Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Fexofenadine Revenue Market Share by Region (2027-2032) Table 122. North America Fexofenadine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Fexofenadine Sales by Country (2021-2026) & (k units) Table 124. North America Fexofenadine Sales by Country (2027-2032) & (k units) Table 125. North America Fexofenadine Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Fexofenadine Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Fexofenadine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Fexofenadine Sales by Country (2021-2026) & (k units) Table 129. Europe Fexofenadine Sales by Country (2027-2032) & (k units) Table 130. Europe Fexofenadine Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Fexofenadine Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Fexofenadine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Fexofenadine Sales by Country (2021-2026) & (k units) Table 134. Asia Pacific Fexofenadine Sales by Country (2027-2032) & (k units) Table 135. Asia Pacific Fexofenadine Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Fexofenadine Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Fexofenadine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Fexofenadine Sales by Country (2021-2026) & (k units) Table 139. South America Fexofenadine Sales by Country (2027-2032) & (k units) Table 140. South America Fexofenadine Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Fexofenadine Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Fexofenadine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Fexofenadine Sales by Country (2021-2026) & (k units) Table 144. Middle East and Africa Fexofenadine Sales by Country (2027-2032) & (k units) Table 145. Middle East and Africa Fexofenadine Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Fexofenadine Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Fexofenadine Sales by Type (2021-2026) & (k units) Table 148. Global Fexofenadine Sales by Type (2027-2032) & (k units) Table 149. Global Fexofenadine Sales Market Share by Type (2021-2026) Table 150. Global Fexofenadine Sales Market Share by Type (2027-2032) Table 151. Global Fexofenadine Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Fexofenadine Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Fexofenadine Revenue Market Share by Type (2021-2026) Table 154. Global Fexofenadine Revenue Market Share by Type (2027-2032) Table 155. Global Fexofenadine Price by Type (2021-2026) & (US$/unit) Table 156. Global Fexofenadine Price by Type (2027-2032) & (US$/unit) Table 157. Global Fexofenadine Sales by Application (2021-2026) & (k units) Table 158. Global Fexofenadine Sales by Application (2027-2032) & (k units) Table 159. Global Fexofenadine Sales Market Share by Application (2021-2026) Table 160. Global Fexofenadine Sales Market Share by Application (2027-2032) Table 161. Global Fexofenadine Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Fexofenadine Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Fexofenadine Revenue Market Share by Application (2021-2026) Table 164. Global Fexofenadine Revenue Market Share by Application (2027-2032) Table 165. Global Fexofenadine Price by Application (2021-2026) & (US$/unit) Table 166. Global Fexofenadine Price by Application (2027-2032) & (US$/unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Fexofenadine Distributors List Table 170. Fexofenadine Customers List Table 171. Fexofenadine Industry Trends Table 172. Fexofenadine Industry Drivers Table 173. Fexofenadine Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Fexofenadine Product Image Figure 5. Global Fexofenadine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Fexofenadine Market Size (2021-2032) & (US$ Million) Figure 7. Global Fexofenadine Sales (2021-2032) & (k units) Figure 8. Global Fexofenadine Average Price (US$/unit) & (2021-2032) Figure 9. Purity:98% Product Image Figure 10. Purity:Above 98% Product Image Figure 11. Hay Fever Treatment Product Image Figure 12. Urticaria Treatment Product Image Figure 13. Global Fexofenadine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Fexofenadine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Fexofenadine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Fexofenadine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Fexofenadine Sales by Region in 2025 Figure 19. Global Fexofenadine Revenue by Region in 2025 Figure 20. North America Fexofenadine Market Size by Country in 2025 Figure 21. North America Fexofenadine Sales Market Share by Country (2021-2032) Figure 22. North America Fexofenadine Revenue Market Share by Country (2021-2032) Figure 23. United States Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Fexofenadine Market Size by Country in 2025 Figure 27. Europe Fexofenadine Sales Market Share by Country (2021-2032) Figure 28. Europe Fexofenadine Revenue Market Share by Country (2021-2032) Figure 29. Germany Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Fexofenadine Market Size by Country in 2025 Figure 40. Asia Pacific Fexofenadine Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Fexofenadine Revenue Market Share by Country (2021-2032) Figure 42. China Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Fexofenadine Market Size by Country in 2025 Figure 51. South America Fexofenadine Sales Market Share by Country (2021-2032) Figure 52. South America Fexofenadine Revenue Market Share by Country (2021-2032) Figure 53. Brazil Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Fexofenadine Market Size by Country in 2025 Figure 57. Middle East and Africa Fexofenadine Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Fexofenadine Revenue Market Share by Country (2021-2032) Figure 59. Egypt Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Fexofenadine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Fexofenadine Sales Market Share by Type (2021-2032) Figure 65. Global Fexofenadine Revenue Market Share by Type (2021-2032) Figure 66. Global Fexofenadine Price (US$/unit) by Type (2021-2032) Figure 67. Global Fexofenadine Sales Market Share by Application (2021-2032) Figure 68. Global Fexofenadine Revenue Market Share by Application (2021-2032) Figure 69. Global Fexofenadine Price (US$/unit) by Application (2021-2032) Figure 70. Fexofenadine Value Chain Figure 71. Fexofenadine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Fexofenadine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Purity:98%
  • Purity:Above 98%
Applications
  • Hay Fever Treatment
  • Urticaria Treatment
Companies covered
  • Zhejiang Excel Pharmaceutical
  • VPL Chemicals
  • Viruj Pharma
  • Va Sudha Pharma Chem Limited
  • Titan Pharma
  • Synkromax
  • Sumitomo Chemical
  • Smaart Pharmaceutticals
  • Sibram
  • Panchsheel
  • JRC
  • Gen Pharma
  • Farmhispania
  • CEPiA-Sanofi
  • Cemex Pharma
  • CAMEO HEALTH CARE
  • Archerchem
  • AFCL
  • Admiron Life Sciences Private Limited

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Fexofenadine Market Size (2021-2032)
  4. 2.2.2 Global Fexofenadine Sales (2021-2032)
  5. 2.2.3 Global Fexofenadine Market Average Price (2021-2032)
  6. 2.3 Fexofenadine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Purity:98%
  9. 2.3.3 Purity:Above 98%
  10. 2.4 Fexofenadine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hay Fever Treatment
  13. 2.4.3 Urticaria Treatment
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Fexofenadine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Fexofenadine Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Fexofenadine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Fexofenadine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Fexofenadine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Fexofenadine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Fexofenadine, Product Type & Application
  8. 3.8 Global Manufacturers of Fexofenadine, Established Date
  9. 3.9 Global Fexofenadine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Excel Pharmaceutical
  2. 4.1.1 Zhejiang Excel Pharmaceutical Company Information
  3. 4.1.2 Zhejiang Excel Pharmaceutical Business Overview
  4. 4.1.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Excel Pharmaceutical Fexofenadine Product Portfolio
  6. 4.1.5 Zhejiang Excel Pharmaceutical Recent Developments
  7. 4.2 VPL Chemicals
  8. 4.2.1 VPL Chemicals Company Information
  9. 4.2.2 VPL Chemicals Business Overview
  10. 4.2.3 VPL Chemicals Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 VPL Chemicals Fexofenadine Product Portfolio
  12. 4.2.5 VPL Chemicals Recent Developments
  13. 4.3 Viruj Pharma
  14. 4.3.1 Viruj Pharma Company Information
  15. 4.3.2 Viruj Pharma Business Overview
  16. 4.3.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Viruj Pharma Fexofenadine Product Portfolio
  18. 4.3.5 Viruj Pharma Recent Developments
  19. 4.4 Va Sudha Pharma Chem Limited
  20. 4.4.1 Va Sudha Pharma Chem Limited Company Information
  21. 4.4.2 Va Sudha Pharma Chem Limited Business Overview
  22. 4.4.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Va Sudha Pharma Chem Limited Fexofenadine Product Portfolio
  24. 4.4.5 Va Sudha Pharma Chem Limited Recent Developments
  25. 4.5 Titan Pharma
  26. 4.5.1 Titan Pharma Company Information
  27. 4.5.2 Titan Pharma Business Overview
  28. 4.5.3 Titan Pharma Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Titan Pharma Fexofenadine Product Portfolio
  30. 4.5.5 Titan Pharma Recent Developments
  31. 4.6 Synkromax
  32. 4.6.1 Synkromax Company Information
  33. 4.6.2 Synkromax Business Overview
  34. 4.6.3 Synkromax Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Synkromax Fexofenadine Product Portfolio
  36. 4.6.5 Synkromax Recent Developments
  37. 4.7 Sumitomo Chemical
  38. 4.7.1 Sumitomo Chemical Company Information
  39. 4.7.2 Sumitomo Chemical Business Overview
  40. 4.7.3 Sumitomo Chemical Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sumitomo Chemical Fexofenadine Product Portfolio
  42. 4.7.5 Sumitomo Chemical Recent Developments
  43. 4.8 Smaart Pharmaceutticals
  44. 4.8.1 Smaart Pharmaceutticals Company Information
  45. 4.8.2 Smaart Pharmaceutticals Business Overview
  46. 4.8.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Smaart Pharmaceutticals Fexofenadine Product Portfolio
  48. 4.8.5 Smaart Pharmaceutticals Recent Developments
  49. 4.9 Sibram
  50. 4.9.1 Sibram Company Information
  51. 4.9.2 Sibram Business Overview
  52. 4.9.3 Sibram Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sibram Fexofenadine Product Portfolio
  54. 4.9.5 Sibram Recent Developments
  55. 4.10 Panchsheel
  56. 4.10.1 Panchsheel Company Information
  57. 4.10.2 Panchsheel Business Overview
  58. 4.10.3 Panchsheel Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Panchsheel Fexofenadine Product Portfolio
  60. 4.10.5 Panchsheel Recent Developments
  61. 4.11 JRC
  62. 4.11.1 JRC Company Information
  63. 4.11.2 JRC Business Overview
  64. 4.11.3 JRC Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 JRC Fexofenadine Product Portfolio
  66. 4.11.5 JRC Recent Developments
  67. 4.12 Gen Pharma
  68. 4.12.1 Gen Pharma Company Information
  69. 4.12.2 Gen Pharma Business Overview
  70. 4.12.3 Gen Pharma Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Gen Pharma Fexofenadine Product Portfolio
  72. 4.12.5 Gen Pharma Recent Developments
  73. 4.13 Farmhispania
  74. 4.13.1 Farmhispania Company Information
  75. 4.13.2 Farmhispania Business Overview
  76. 4.13.3 Farmhispania Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Farmhispania Fexofenadine Product Portfolio
  78. 4.13.5 Farmhispania Recent Developments
  79. 4.14 CEPiA-Sanofi
  80. 4.14.1 CEPiA-Sanofi Company Information
  81. 4.14.2 CEPiA-Sanofi Business Overview
  82. 4.14.3 CEPiA-Sanofi Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 CEPiA-Sanofi Fexofenadine Product Portfolio
  84. 4.14.5 CEPiA-Sanofi Recent Developments
  85. 4.15 Cemex Pharma
  86. 4.15.1 Cemex Pharma Company Information
  87. 4.15.2 Cemex Pharma Business Overview
  88. 4.15.3 Cemex Pharma Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Cemex Pharma Fexofenadine Product Portfolio
  90. 4.15.5 Cemex Pharma Recent Developments
  91. 4.16 CAMEO HEALTH CARE
  92. 4.16.1 CAMEO HEALTH CARE Company Information
  93. 4.16.2 CAMEO HEALTH CARE Business Overview
  94. 4.16.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CAMEO HEALTH CARE Fexofenadine Product Portfolio
  96. 4.16.5 CAMEO HEALTH CARE Recent Developments
  97. 4.17 Archerchem
  98. 4.17.1 Archerchem Company Information
  99. 4.17.2 Archerchem Business Overview
  100. 4.17.3 Archerchem Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Archerchem Fexofenadine Product Portfolio
  102. 4.17.5 Archerchem Recent Developments
  103. 4.18 AFCL
  104. 4.18.1 AFCL Company Information
  105. 4.18.2 AFCL Business Overview
  106. 4.18.3 AFCL Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 AFCL Fexofenadine Product Portfolio
  108. 4.18.5 AFCL Recent Developments
  109. 4.19 Admiron Life Sciences Private Limited
  110. 4.19.1 Admiron Life Sciences Private Limited Company Information
  111. 4.19.2 Admiron Life Sciences Private Limited Business Overview
  112. 4.19.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Admiron Life Sciences Private Limited Fexofenadine Product Portfolio
  114. 4.19.5 Admiron Life Sciences Private Limited Recent Developments
5 Global Fexofenadine Market Scenario by Region
  1. 5.1 Global Fexofenadine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Fexofenadine Sales by Region: 2021-2032
  3. 5.2.1 Global Fexofenadine Sales by Region: 2021-2026
  4. 5.2.2 Global Fexofenadine Sales by Region: 2027-2032
  5. 5.3 Global Fexofenadine Revenue by Region: 2021-2032
  6. 5.3.1 Global Fexofenadine Revenue by Region: 2021-2026
  7. 5.3.2 Global Fexofenadine Revenue by Region: 2027-2032
  8. 5.4 North America Fexofenadine Market Facts & Figures by Country
  9. 5.4.1 North America Fexofenadine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Fexofenadine Sales by Country (2021-2032)
  11. 5.4.3 North America Fexofenadine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Fexofenadine Market Facts & Figures by Country
  16. 5.5.1 Europe Fexofenadine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Fexofenadine Sales by Country (2021-2032)
  18. 5.5.3 Europe Fexofenadine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Fexofenadine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Fexofenadine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Fexofenadine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Fexofenadine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Fexofenadine Market Facts & Figures by Country
  41. 5.7.1 South America Fexofenadine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Fexofenadine Sales by Country (2021-2032)
  43. 5.7.3 South America Fexofenadine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Fexofenadine Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Fexofenadine Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Fexofenadine Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Fexofenadine Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Fexofenadine Sales by Type (2021-2032)
  2. 6.1.1 Global Fexofenadine Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Fexofenadine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Fexofenadine Revenue by Type (2021-2032)
  5. 6.2.1 Global Fexofenadine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Fexofenadine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Fexofenadine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Fexofenadine Sales by Application (2021-2032)
  2. 7.1.1 Global Fexofenadine Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Fexofenadine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Fexofenadine Revenue by Application (2021-2032)
  5. 7.2.1 Global Fexofenadine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Fexofenadine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Fexofenadine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Fexofenadine Value Chain Analysis
  2. 8.1.1 Fexofenadine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Fexofenadine Production Mode & Process
  5. 8.2 Fexofenadine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Fexofenadine Distributors
  8. 8.2.3 Fexofenadine Customers
9 Global Fexofenadine Analyzing Market Dynamics
  1. 9.1 Fexofenadine Industry Trends
  2. 9.2 Fexofenadine Industry Drivers
  3. 9.3 Fexofenadine Industry Opportunities and Challenges
  4. 9.4 Fexofenadine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst